http://www.xconomy.com/seattle/2009/05/06/acucela-drug-for-macular-degeneration-passes-early-safety-test/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/seattle/2009/05/06/acucela-drug-for-macular-degeneration-passes-early-safety-test/comment-page-1/#comment-56658 ARVO Presentation Roundup: Uveitis, Lucentis, IOP, Retinal Detachment, Dry AMD, Bacterial Conjunctivitis, Glaucoma : Eye Doc News Thu, 07 May 2009 16:13:11 +0000 http://www.xconomy.com/?p=23369#comment-56658 [...] Acucela Oral Pill for Dry AMD: Acucela presented preliminary data showing that its oral pill for treatment of the “dry” form of age-related macular degeneration, ACU-4429, has passed an early safety test and is ready to advance to a preliminary Phase II clinical trial this summer of 30 to 40 patients that will examine whether the treatment can successfully help preserve vision.  Read more. [...] [...] Acucela Oral Pill for Dry AMD: Acucela presented preliminary data showing that its oral pill for treatment of the “dry” form of age-related macular degeneration, ACU-4429, has passed an early safety test and is ready to advance to a preliminary Phase II clinical trial this summer of 30 to 40 patients that will examine whether the treatment can successfully help preserve vision.  Read more. [...]

]]>